{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T13:15:43Z","timestamp":1791292543243,"version":"4.1.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2005,9,1]],"date-time":"2005-09-01T00:00:00Z","timestamp":1125532800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,9,1]],"date-time":"2005-09-01T00:00:00Z","timestamp":1125532800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,4,10]],"date-time":"2015-04-10T00:00:00Z","timestamp":1428624000000},"content-version":"vor","delay-in-days":3508,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["bbmt.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biology of Blood and Marrow Transplantation"],"published-print":{"date-parts":[[2005,9]]},"DOI":"10.1016\/j.bbmt.2005.05.009","type":"journal-article","created":{"date-parts":[[2005,8,26]],"date-time":"2005-08-26T08:14:49Z","timestamp":1125044089000},"page":"680-687","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":82,"title":["Pilot Trial on the Use of Etanercept and Methylprednisolone as Primary Treatment for Acute Graft-versus-Host Disease"],"prefix":"10.1016","volume":"11","author":[{"given":"Joseph P.","family":"Uberti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lois","family":"Ayash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Voravit","family":"Ratanatharathorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Silver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Reynolds","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Becker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pavan","family":"Reddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth R.","family":"Cooke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory","family":"Yanik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel","family":"Whitfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dawn","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond","family":"Hutchinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Braun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James L.M.","family":"Ferrara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John E.","family":"Levine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbmt.2005.05.009_bib1","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1056\/NEJM198603203141201","article-title":"Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft versus host disease after bone marrow transplantation for leukemia","volume":"314","author":"Storb","year":"1986","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bbmt.2005.05.009_bib2","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1182\/blood.V71.2.293.293","article-title":"Cyclosporine v methotrexate for graft-v-host disease prevention in patients given marrow grafts for leukemia","volume":"71","author":"Storb","year":"1988","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2005.05.009_bib3","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1111\/j.1365-2141.1989.tb04325.x","article-title":"Graft versus host disease prevention by methotrexate combined with cyclosporin compared to methotrexate alone in patients given marrow grafts for severe aplastic anaemia","volume":"72","author":"Storb","year":"1989","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bbmt.2005.05.009_bib4","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1182\/blood.V73.6.1729.1729","article-title":"Methotrexate and cyclosporine versus cyclosporine alone for prophylaxis of graft-versus-host disease in patients given HLA-identical marrow grafts for leukemia","volume":"73","author":"Storb","year":"1989","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2005.05.009_bib5","first-page":"2303","article-title":"Phase III study comparing methotrexate and tacrolimus (prograf, FK506) with methotrexate and cyclosporine for graft-versus-host disease prophylaxis after HLA-identical sibling bone marrow transplantation","volume":"92","author":"Ratanatharathorn","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2005.05.009_bib6","first-page":"2062","article-title":"Phase 3 study comparing methotrexate and tacrolimus with methotrexate and cyclosporine for prophylaxis of acute graft-versus-host disease after marrow transplantation from unrelated donors","volume":"96","author":"Nash","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2005.05.009_bib7","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1182\/blood.V76.8.1464.1464","article-title":"A retrospective analysis of therapy for acute graft-versus-host disease","volume":"76","author":"Martin","year":"1990","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2005.05.009_bib8","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1053\/bbmt.2002.v8.pm12171485","article-title":"Response of 443 patients to steroids as primary therapy for acute graft-versus-host disease","volume":"8","author":"MacMillan","year":"2002","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2005.05.009_bib9","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/S1083-8791(00)70036-X","article-title":"A randomized trial comparing prednisone with antithymocyte globulin\/prednisone as an initial systemic therapy for moderately severe acute graft-versus-host disease","volume":"6","author":"Cragg","year":"2000","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2005.05.009_bib10","first-page":"2288","article-title":"Early treatment of acute graft-versus-host disease with high-or-low-dose 6-methylprednisolone","volume":"92","author":"Van Lint","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2005.05.009_bib11","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1182\/blood.V77.8.1821.1821","article-title":"A retrospect of analysis of therapy for acute GVHD","volume":"77","author":"Martin","year":"1991","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2005.05.009_bib12","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S1083-8791(99)70011-X","article-title":"Pathophysiolgic mechanisms of acute graft-versus-host disease","volume":"5","author":"Ferrara","year":"1999","journal-title":"Biol Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2005.05.009_bib13","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1084\/jem.166.5.1280","article-title":"Tumor necrosis factor\/cachectin is an effector of skin and gut lesions of the acute phase of graft-vs-host disease","volume":"166","author":"Piguet","year":"1987","journal-title":"J Exp Med"},{"key":"10.1016\/j.bbmt.2005.05.009_bib14","doi-asserted-by":"crossref","first-page":"2754","DOI":"10.1182\/blood.V95.9.2754.009k25_2754_2759","article-title":"The primacy of gastrointestinal tract as a target organ of acute graft-versus-host disease","volume":"95","author":"Hill","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2005.05.009_bib15","doi-asserted-by":"crossref","first-page":"3204","DOI":"10.1182\/blood.V90.8.3204","article-title":"Total body irradiation and acute graft-versus-host disease","volume":"90","author":"Hill","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2005.05.009_bib16","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1172\/JCI4285","article-title":"Tumor necrosis factor alpha production to lipopolysaccharide stimulation by donor cells predicts the severity of experimental acute graft-versus-host disease","volume":"102","author":"Cooke","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1016\/j.bbmt.2005.05.009_bib17","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/nm0602-575","article-title":"Acute graft-versus-host disease does not require alloantigen expression on host epithelium","volume":"8","author":"Teshima","year":"2002","journal-title":"Nat Med"},{"key":"10.1016\/j.bbmt.2005.05.009_bib18","first-page":"99","article-title":"TNF alpha levels are increased during bone marrow transplantation conditioning in patients who develop acute GVHD","volume":"15","author":"Remberger","year":"1995","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2005.05.009_bib19","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1182\/blood.V75.4.1011.1011","article-title":"Increased serum levels of tumor necrosis factor alpha precede major complications of bone marrow transplantation","volume":"75","author":"Holler","year":"1990","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2005.05.009_bib20","first-page":"1234","article-title":"Role of tumor necrosis factor alpha in acute graft-versus-host disease and complications following allogeneic bone marrow transplantation","volume":"25","author":"Holler","year":"1993","journal-title":"Transplant Proc"},{"key":"10.1016\/j.bbmt.2005.05.009_bib21","doi-asserted-by":"crossref","first-page":"3362","DOI":"10.1182\/blood.V79.12.3362.bloodjournal79123362","article-title":"Phase I-II trial of a monoclonal anti-tumor necrosis factor alpha for the treatment of refractory severe acute graft versus disease","volume":"79","author":"Herve","year":"1992","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2005.05.009_bib22","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1182\/blood.V86.3.890.890","article-title":"Modulation of acute graft-versus-host disease after allogeneic bone marrow transplantation by tumor necrosis factor \u03b1 (TNF \u03b1) release in the course of pretransplant conditioning","volume":"86","author":"Holler","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2005.05.009_bib23","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.2165\/00003495-200059060-00010","article-title":"Infliximab","volume":"59","author":"Markham","year":"2000","journal-title":"Drugs"},{"key":"10.1016\/j.bbmt.2005.05.009_bib24","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1056\/NEJM199905063401804","article-title":"Infliximab for the treatment of fistulas in patients with Crohn\u2019s disease","volume":"340","author":"Present","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bbmt.2005.05.009_bib25","first-page":"399a","article-title":"Salvage therapy with infliximab for patients with severe acute and chronic GVHD","volume":"98","author":"Redei","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2005.05.009_bib26","first-page":"5208a","article-title":"Treatment of severe steroid refractory acute graft versus host disease with infliximab","volume":"98","author":"Magalhaes-Silverman","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2005.05.009_bib27","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/sj.bmt.1703094","article-title":"Treatment of severe steroid refractory acute graft-versus-host disease with infliximab, a chimeric human\/mouse anti TNF alpha antibody","volume":"28","author":"Kobbe","year":"2001","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2005.05.009_bib28","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1182\/blood-2003-12-4241","article-title":"Tumor necrosis factor alpha blockade for the treatment of acute GVHD","volume":"104","author":"Couriel","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2005.05.009_bib29","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1056\/NEJM199901283400401","article-title":"A trial of etanercept, a recombinant tumor necrosis factor receptor","volume":"340","author":"Weinblatt","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bbmt.2005.05.009_bib30","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S0140-6736(00)02530-7","article-title":"Etanercept in the treatment of psoriatic arthritis and psoriasis","volume":"356","author":"Mease","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.bbmt.2005.05.009_bib31","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1038\/sj.bmt.1702638","article-title":"Etanercept in graft-versus-host disease","volume":"26","author":"Andolina","year":"2000","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2005.05.009_bib32","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1097\/00007890-200202270-00035","article-title":"Recombinant human necrosis factor receptor fusion protein as complementary treatment for chronic graft-versus-host disease","volume":"73","author":"Chiang","year":"2002","journal-title":"Transplantation"},{"key":"10.1016\/j.bbmt.2005.05.009_bib33","first-page":"825","article-title":"1994 Consensus conference on acute GVHD grading","volume":"15","author":"Przepiorka","year":"1995","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2005.05.009_bib34","doi-asserted-by":"crossref","first-page":"3479","DOI":"10.1182\/blood-2002-03-0985","article-title":"Interleukin-1 blockade does not prevent acute graft-versus-host disease","volume":"100","author":"Antin","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2005.05.009_bib35","doi-asserted-by":"crossref","first-page":"2768","DOI":"10.1182\/blood-2003-01-0267","article-title":"Infliximab use in patients with severe graft-versus-host disease and other emerging risk factors of non-Candida invasive fungal infections in allogeneic hematopoietic stem cell transplant recipients","volume":"102","author":"Marty","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2005.05.009_bib36","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1006\/cyto.1995.0029","article-title":"Chimeric anti-TNF-alpha monoclonal antibody cA2 binds recombinant transmembrane TNF-alpha and activates immune effector functions","volume":"7","author":"Scallon","year":"1995","journal-title":"Cytokine"},{"key":"10.1016\/j.bbmt.2005.05.009_bib37","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/00000441-200302000-00005","article-title":"New indications for treatment of chronic inflammation by TNF-\u03b1 blockade","volume":"325","author":"Reimold","year":"2003","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.bbmt.2005.05.009_bib38","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1056\/NEJMoa022060","article-title":"Relation of interleukin-10 promoter polymorphism to graft-versus-host disease and survival after hematopoietic cell transplantation","volume":"349","author":"Lin","year":"2004","journal-title":"N Engl J Med"}],"container-title":["Biology of Blood and Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879105003228?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879105003228?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T14:24:02Z","timestamp":1761056642000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1083879105003228"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,9]]},"references-count":38,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2005,9]]}},"alternative-id":["S1083879105003228"],"URL":"https:\/\/doi.org\/10.1016\/j.bbmt.2005.05.009","relation":{},"ISSN":["1083-8791"],"issn-type":[{"value":"1083-8791","type":"print"}],"subject":[],"published":{"date-parts":[[2005,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pilot Trial on the Use of Etanercept and Methylprednisolone as Primary Treatment for Acute Graft-versus-Host Disease","name":"articletitle","label":"Article Title"},{"value":"Biology of Blood and Marrow Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbmt.2005.05.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 American Society for Blood and Marrow Transplantation. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}